Skip to main content
FISCHER · Health Care · 2026-08-07

Fischer Medical Ventures Ltd

Stage 1 · wk 3MARKET: BULL TOPPING · 2026-08-07
₹38
+1.50% today
₹2,488 Cr · Small cap
About this companyHealth Care· Health Care Equipment & Supplies
Expand ▾

Fischer Medical Ventures Limited engages in the manufacture, distribution, leasing, and maintenance of medical equipment in India and internationally. Its product portfolio includes magnetic resonance imaging (MRI) systems; preventive health kiosks; e-health access points; software solutions; cancer, TB screening, and handheld x-ray; spincare technology; nutraceuticals from plant extracts; mental health solutions; contactless screening solutions; and CT scan systems, as well as preventive diagnostic devices and ancillary medical instruments. The company was formerly known as Fischer Chemic Limited and changed its name to Fischer Medical Ventures Limited in March 2024. Fischer Medical Ventures Limited was incorporated in 1993 and is headquartered in Chennai, India.

Visit company website →
P/E (TTM)
63.5
Forward —
Dividend Yield
0.01%
P/B 6.7
vs 52W High
-67.7%
₹31.2 lo₹117.7 hi
67.7% below 52W high
Stock is basing below old highs. A volume-backed breakout to new highs would be the Stage 2 signal to watch.
Stage Maturity
Week 3
1w13w26w
Week 3 — early base, needs time
How long this stock has been basing. Longer bases can produce stronger breakouts — but don't anticipate, wait for the breakout.
vs 200 DMA
-15.2%
200 DMA: ₹44.8 · sloping down
Stock is testing its 200 DMA as part of the base. Reclaiming and holding above it is a key Stage 2 prerequisite.
Rel Volume
1.56x
vs 50-day avg
Volume in Stage 1 basing is typically quiet. A surge in volume on an upside breakout is the signal to watch.
Trend Health
MA20 rolling over · -1.3% vs MA50 +1.9%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
Sector
Health Care
↑ Building
Stage 2%
51.6%
20d Δ
+1.6pp
1M return
+3.1%
3M return
+11.6%
Sector Stage-2 % · last 20 days
Sector has 79 Stage 2 leaders. See Health Care Stage 2 →
Industry
Health Care Equipment & Supplies
→ Flat
Stage 2%
37.5%
20d Δ
+0.0pp
1M return
-2.4%
3M return
+3.7%
Industry Stage-2 % · last 20 days
Industry has 3 Stage 2 leaders. See Health Care Equipment & Supplies Stage 2 →
Price + Volume Chart
Loading price chart…
Stage Cycle Timeline2025-07-10 → 2026-08-07
S? 42w
S4 11w
2025-07-102026-08-07
S1S2S3S4Setup score (0–10, dashed line at 5)
S? 42w → S1 1w → S4 11w → S1 2w current
Total tracked: 56 weeks across 4 stage runs.
1M
-0.2%
3M
+1.7%
6M
+4.0%
YTD
-8.8%
1Y
-60.6%
Scan Membership
Not in any current scan.
Recent Stage Timeline
2026-08-07S1
Wk 3 · Vol x
2026-08-06S1
Wk 2 · Vol x
2026-08-05S1
Wk 2 · Vol x
2026-08-04S1
Wk 2 · Vol x
2026-08-03S1
Wk 2 · Vol x
2026-07-31S1
Wk 2 · Vol x
2026-07-30S1
Wk 1 · Vol x
2026-07-29S1
Wk 1 · Vol x
2026-07-28S1
Wk 1 · Vol x
2026-07-27S1
Wk 1 · Vol x
2026-07-24S14→1
Wk 1 · Vol x
2026-07-23S4
Wk 11 · Vol x
Sector Peers — Stage 2All →
DIVISLAB
wk 12 · -3.6% from hi
8.5
LAURUSLABS
wk 16 · -0.3% from hi
8.4
PPLPHARMA
wk 4 · 0.0% from hi
8.2
LALPATHLAB
wk 9 · 0.0% from hi
7.9
SHILPAMED
wk 13 · 0.0% from hi
7.8
Moving averages & range
50 DMA
₹37
200 DMA
₹44.8
52W High
₹117.7
52W Low
₹31.2
5D Low
₹37.5
Resistance levels (recent highs)
20d High
₹40
60d High
₹41.7
120d High
₹42.4
250d High
₹117.7
Next resistance
+5.2%
to 20d High

All analytics based on EOD data. Data as of 2026-08-07. Past data patterns are not indicative of future results. This page is a data analytics tool only.